InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Addex Therapeutics Ltd.

ADXN Clue Score51
Switzerland Fiscal year ends December CIK 0001574232
$3.22 +1.21% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.22 −62.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Jan 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−3.2Net income−3.3Fiscal year 2018Revenue6.0Operating income−1.4Net income−1.6Fiscal year 2019Revenue2.8 −54.3%Operating income−14.6Net income−14.8EPS, diluted−0.56Fiscal year 2020Revenue3.6 +30.8%Operating income−12.2Net income−12.9EPS, diluted−0.48Fiscal year 2021Revenue2.9 −19.3%Operating income−15.5Net income−15.4EPS, diluted−0.45Fiscal year 2022Revenue1.4 −51.2%Operating income−10.5Net income−20.8EPS, diluted−0.46Fiscal year 2023Revenue1.6 +13.4%Operating income−2.2Net income−10.6EPS, diluted−0.14Fiscal year 2024Revenue0.4 −74.9%Operating income−2.8Net income7.1EPS, diluted0.07
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue n/a 6.0 2.8 3.6 2.9 1.4 1.6 0.4
Growth −54.3% +30.8% −19.3% −51.2% +13.4% −74.9%
Operating income −3.2 −1.4 −14.6 −12.2 −15.5 −10.5 −2.2 −2.8
Net income −3.3 −1.6 −14.8 −12.9 −15.4 −20.8 −10.6 7.1
Growth
EPS, diluted n/a n/a −0.56 −0.48 −0.45 −0.46 −0.14 0.07
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Operating margin−23.6%Net margin−27.2%Free cash flow margin28.8%Fiscal year 2019Operating margin−528.6%Net margin−535.0%Free cash flow margin−344.2%Fiscal year 2020Operating margin−338.9%Net margin−355.9%Free cash flow margin−338.8%Fiscal year 2021Operating margin−531.7%Net margin−526.4%Free cash flow margin−505.3%Fiscal year 2022Operating margin−741.0%Net margin−1,462.6%Free cash flow margin−1,155.6%Fiscal year 2023Operating margin−139.1%Net margin−654.5%Free cash flow margin−495.9%Fiscal year 2024Operating margin−681.8%Net margin1,746.0%Free cash flow margin−1,330.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating margin n/a −23.6% −528.6% −338.9% −531.7% −741.0% −139.1% −681.8%
Net margin n/a −27.2% −535.0% −355.9% −526.4% −1,462.6% −654.5% 1,746.0%
Free cash flow margin n/a 28.8% −344.2% −338.8% −505.3% −1,155.6% −495.9% −1,330.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−2.1Capital expenditure−0.0Free cash flow−2.1Fiscal year 2018Operating cash flow1.8Capital expenditure−0.0Free cash flow1.7Fiscal year 2019Operating cash flow−9.5Capital expenditure−0.0Free cash flow−9.5 −645.7%Fiscal year 2020Operating cash flow−12.2Capital expenditure−0.1Free cash flow−12.2Fiscal year 2021Operating cash flow−14.7Capital expenditure−0.0Free cash flow−14.7Fiscal year 2022Operating cash flow−16.4Capital expenditure−0.0Free cash flow−16.4Fiscal year 2023Operating cash flow−8.0Capital expenditure−0.0Free cash flow−8.0Fiscal year 2024Operating cash flow−5.4Capital expenditure−0.0Free cash flow−5.4
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow −2.1 1.8 −9.5 −12.2 −14.7 −16.4 −8.0 −5.4
Capital expenditure −0.0 −0.0 −0.0 −0.1 −0.0 −0.0 −0.0 −0.0
Free cash flow −2.1 1.7 −9.5 −12.2 −14.7 −16.4 −8.0 −5.4
Growth −645.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash2.6Shareholders’ equity1.3Fiscal year 2018Cash31.5Total debt0.0Net cash (debt)31.5Shareholders’ equity39.2Debt to equity0.00Fiscal year 2019Cash31.5Total debt0.0Net cash (debt)31.5Shareholders’ equity25.5Debt to equity0.00Fiscal year 2020Cash18.7Total debt0.0Net cash (debt)18.7Shareholders’ equity14.6Debt to equity0.00Fiscal year 2021Cash20.5Total debt0.0Net cash (debt)20.5Shareholders’ equity16.9Debt to equity0.00Fiscal year 2022Cash7.0Total debt0.0Net cash (debt)7.0Shareholders’ equity4.9Debt to equity0.00Fiscal year 2023Cash3.9Total debt0.0Net cash (debt)3.9Shareholders’ equity1.1Debt to equity0.00Fiscal year 2024Cash3.3Total debt0.0Net cash (debt)3.3Shareholders’ equity9.7Debt to equity0.00
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash 2.6 31.5 31.5 18.7 20.5 7.0 3.9 3.3
Total debt n/a 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Net cash (debt) n/a 31.5 31.5 18.7 20.5 7.0 3.9 3.3
Shareholders’ equity 1.3 39.2 25.5 14.6 16.9 4.9 1.1 9.7
Debt to equity n/a 0.00 0.00 0.00 0.00 0.00 0.00 0.00

In millions of CHF, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Cash flow

In millions of CHF, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Operations
−2.1 1.8 −9.5 −12.2 −14.7 −16.4 −8.0 −5.4
Growth −641.3%
Investment
−0.0 −0.0 −0.0 −0.1 −0.0 −0.0 −0.0 −0.0
calc −2.1 1.7 −9.5 −12.2 −14.7 −16.4 −8.0 −5.4
Growth −645.7%
−0.0 −0.1 −0.0 −0.1 −0.0 0.0 −0.0 4.6
Financing
3.4 37.4 −0.5 0.0 16.4 3.1 5.3 0.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in CHF as filed; the screener converts to dollars.